[go: up one dir, main page]

WO2010015812A1 - Amélioration de réponse électrochimique - Google Patents

Amélioration de réponse électrochimique Download PDF

Info

Publication number
WO2010015812A1
WO2010015812A1 PCT/GB2009/001911 GB2009001911W WO2010015812A1 WO 2010015812 A1 WO2010015812 A1 WO 2010015812A1 GB 2009001911 W GB2009001911 W GB 2009001911W WO 2010015812 A1 WO2010015812 A1 WO 2010015812A1
Authority
WO
WIPO (PCT)
Prior art keywords
current
measurements
potential
period
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2009/001911
Other languages
English (en)
Inventor
Howard James Orman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of WO2010015812A1 publication Critical patent/WO2010015812A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3273—Devices therefor, e.g. test element readers, circuitry

Definitions

  • the present invention relates to methods for determining the concentration of an analyte in a sample by an electrochemical method involving application of a potential and measuring the electrochemical response of the system during a period of enhanced current.
  • Electrochemical methodology is a versatile technique well suited to detecting many parameters of a substance. For example, the presence or concentration of a test analyte in a sample can be detected electrochemically by containing the sample in an electrochemical cell, applying a potential across the cell and probing the resulting electrochemical response.
  • the concentration of an analyte in a sample can be determined by measuring an electrochemical parameter and comparing that measurement with control measurements obtained on samples having known analyte concentrations. For example, in chronoamperometry a potential difference is applied across an electrochemical cell and the time-dependent current response (the "current transient") of the cell is measured. The current transient measured in an electrochemical test is related to current transients obtained for control samples (i.e., samples comprising known amounts of analyte) and so can be used to determine the concentration of the test analyte.
  • a time- varying potential is applied to step the potential applied across two electrodes in electrical contact with a target solution between an initial and a final potential.
  • the current flowing between the electrodes is sampled.
  • the current flowing between the electrodes is readily predictable using well-known theoretical equations suitable for a particular system under study.
  • Such equations typically include as variables features of the system such as electrode shape and size, cell configuration, nature of the sample, and so on.
  • electrochemical measurements of this type typically comprise a contribution to the observed current in a period shortly after application of the potential that is not readily derivable by such equations.
  • One well-known aspect of this contribution at very small times after application of the potential is the so-called “charging current” which is caused by capacitive electron flow in the electrochemical cell.
  • the shape of the "charging current” response is dependent on a number of factors, such as electrical configuration of the electrochemical cell, electrical configuration of the electronics and solution resistance.
  • this current enhancement means that it often has a "shoulder" shape in an observed current transient.
  • shoulder can refer not only to a clearly visible shoulder in a current transient, but more generally to any enhancement of current that comprises a peak in time and a subsequent decay in magnitude.
  • shoulderers or “current enhancements” that are addressed herein are typically not attributable to the non- faradaic charging peaks.
  • the present invention provides a method for determining the concentration of an analyte in a sample, which method comprises: a) contacting said sample with an electrochemical cell comprising at least two electrodes; b) applying a potential across the electrodes to generate a current; c) obtaining one or more measurements of said current under conditions such that at least one of said measurements occurs in a period of enhanced current; and d) determining the concentration of said analyte from said one or more measurements; wherein said period of enhanced current is an enhancement of current for at least a part of the time from zero to ten seconds after application of the potential compared to a predicted current derivable by: i) determining the relationship between the current and time in a period of time beginning at least ten seconds after application of the potential; and ii) using that relationship to extrapolate a predicted current for the period of time from application of the potential to ten seconds after application of the potential.
  • the present inventors have found, surprisingly, that measurements of current generated during the period of enhanced current following application of the potential, before the system reverts to a theoretically predictable behaviour, can be used to determine the concentration of analyte in a sample in a reliable, reproducible way. This is in direct contrast to previous methods in which the "shoulder period" typically observed in the period immediately after application of the potential was considered to be an undesirable signal distortion and therefore not amenable to quantitative analysis.
  • An advantage of the present invention is that it allows the concentration of analyte in a sample to be determined from current generated following application of a potential in a period of enhanced response.
  • this enhanced response can be quantitatively related to analyte concentration means that the relative size of the desired signal is substantially increased compared, in particular, to the electrochemical background response (as well as any errors resulting from other sources). This can be particularly important in systems characterised by small current responses, such as microelectrode systems, in particular biosensors and the like. Still further, measurement in the period of enhanced current allows the electrochemical method to be performed more rapidly, since it is not necessary to delay making measurements until the shoulder has decayed to a substantially negligible magnitude.
  • Figure 1 shows a device according to one embodiment of the present invention.
  • Figure 2 shows experimental transient current responses for two samples containing 7.5 mM NADH in an NADH assay, compared to a theoretical response derived using microband theory.
  • Graph A shows a sample containing n-heptyl- ⁇ -D- glucopyranoside surfactant;
  • graph B shows a sample containing Cymal-4 surfactant. Black lines are the observed current responses and broken lines are the theoretical responses.
  • Figure 3 shows experimental transient current responses for samples containing 2.5 mM NADH (graph A), 5.0 mM NADH (graph B) and 7.5 mM NADH (graph C), compared to a theoretical response derived using microband theory. Black lines are the observed current responses and grey lines are the theoretical responses.
  • Figure 4 shows current response at specific times in the transient current response as a function of NADH concentration.
  • Graph A shows samples containing Cymal 3 surfactant and graph B shows samples containing HEGA 9 surfactant.
  • Current responses at 1 second are the black lines/black diamonds; current responses at 3 seconds are the broken lines/crosses; current responses at 8 seconds are the grey lines/grey circles.
  • Figure 5 shows the cumulative difference between the area under the curve of (i) actual current response and (ii) theoretical response derived using microband theory as a function of time after application of potential to NADH assay samples.
  • Black lines show assays at 7.5 mM NADH; grey lines show assays at 5 mM NADH; broken lines show assays at 2.5 mM NADH.
  • Figure 6 shows the cumulative current response, integrated up to specific times in the transient current response, as a function of NADH concentration, for NADH assay samples containing a Cymal 3 surfactant.
  • the black line/black diamonds show cumulative current response integrated up to 8 seconds; the broken line/crosses show cumulative current response integrated up to 3 seconds; the grey line/grey circles show cumulative current response integrated up to 1 second.
  • Figure 7 shows the cumulative current response, integrated up to specific times in the transient current response, as a function of NADH concentration, for NADH assay samples containing a HEGA 9 surfactant.
  • the black line/black diamonds show cumulative current response integrated up to 8 seconds; the broken line/crosses show cumulative current response integrated up to 3 seconds; the grey line/grey circles show cumulative current response integrated up to 1 second.
  • the present invention involves applying a potential to an electrochemical system under conditions such that the current transient generated comprises a period of enhanced current.
  • a convenient means of defining the "period of enhanced current" in the context of the present invention is that it is an enhancement of current for at least a part of the time from zero to ten seconds after application of the potential compared to a predicted current derivable by: determining the relationship between the current and time in a period of time beginning at least ten seconds after application of the potential; and using that relationship to extrapolate a predicted current for the period of time from application of the potential to ten seconds after application of the potential.
  • the current enhancement has decayed to a negligible level by the period of time beginning at least ten seconds after application of the potential. Therefore, the current response of the system in the period of time beginning at least ten seconds after application of the potential can be used to determine the relationship between the current and time that would be expected for the system based on its physical characteristics (electrode design, size, etc.) and the chemistry occurring in it. By extrapolating this relationship back to give predicted current for the period from application of the potential to ten seconds after application of the potential, one can readily identify the period of time over which the current enhancement occurs.
  • the predicted current is derivable by determining the relationship between the current and time in a period of time beginning at least twelve seconds after application of the potential, for example at least fifteen or at least twenty seconds after application of the potential.
  • the current enhancement in a particular system will have decayed to a negligible level in a shorter time than ten seconds after application of the potential.
  • the predicted current is derivable by determining the relationship between the current and time in a period of time beginning less than ten seconds after application of the potential.
  • the predicted current is derivable by determining the relationship between the current and time in a period of time beginning at least five seconds after application of the potential, for example at least eight seconds.
  • the relationship between the current and time in a period of time beginning at least ten seconds after application of the potential can be determined entirely empirically based on applying a fit to real experimental data.
  • the experimental data may, for example, correspond to current transients obtained in one or more control experiments using known analyte concentrations.
  • the relationship between the current and time in a period of time beginning at least ten seconds after application of the potential can be determined using well known theoretical equations that predict the current response of a known system to a known applied potential. For example, according to Electrochemical Methods: Fundamentals and Applications, A. J. Bard and L. R. Faulkner, John Wiley & Sons, New York, 2" Edition, 2001, Chapter 5, page 175 and to Journal of
  • / is the microband current
  • F is a constant
  • A is the electrode area
  • n is the number of electrons involved in the electrochemical reaction
  • D 0x is the diffusion coefficient of the oxidisable redox agent
  • [Ox] is the concentration of the oxidisable redox agent
  • w is the width of the microband electrode
  • t is the time.
  • the deviation of the current observed in an experiment from this current-time relationship in the period before ten seconds after application of the potential can be used to identify the period of enhanced current. It will also be appreciated it is not necessary to know the concentration of the analyte in advance, since even in the absence of such information the above equation indicates the predicted shape of the current transient, provided that the diffusion coefficient (D 0x ) remains substantially constant over all samples.
  • the diffusion coefficient could, for example, be a quantity having a known magnitude from the characteristics of the compounds making up the sample. Alternatively, the diffusion coefficient could be determined empirically by fitting it to the above equation for a particular experimentally observed
  • the present invention is useful in the electrochemical analysis of a test analyte comprised in a sample.
  • suitable samples include biological and non-biological substances, including water, beer, wine, blood, plasma, sweat, tears and urine samples.
  • the sample is a liquid sample, and more preferably it is an aqueous sample.
  • Suitable test analytes include transition metals and their salts, heavy metals, and physiological species such as enzymes, cholesterol, triglycerides, glucose, cations, anions, biomarkers and biological analytes of clinical interest.
  • the analyte is cholesterol or triglyceride.
  • Cholesterol can be HDL cholesterol, LDL cholesterol or total cholesterol.
  • Electrochemical methods to which the present invention can be applied include any electrochemical method where a current enhancement occurs after a potential has been applied across the electrodes.
  • the electrochemical method comprises applying a potential across the electrodes and measuring the electrochemical response, namely the current response.
  • the electrochemical method is any method in which a steady- state or a substantially steady state current is expected to be achieved following application of a potential.
  • the present invention can be applied to microelectrode systems and to macroelectrode systems, non-exhaustive examples being thin layer cells, flow cells and rotating disc electrodes.
  • the invention can also be used in non- steady state electrochemical methods.
  • Pseudocapacitance is an electrochemical term relating to the electrochemistry of surface-active groups on an electrode surface and may be at least partially responsible for the enhancements observed when a potential is applied to the electrodes.
  • Pseudocapacitance comprises both a capacitive term and a resistive term.
  • the current resulting from pseudocapacitance can take many seconds to dissipate and so result in a shoulder in a measured transient, for example a current transient.
  • the capacitive term varies according to the material adsorbed on the electrode (for example, surfactant micelles, proteins), while changes in the ionic strength of the solution may result in increases or decreases in the resistance of the solution and thus alter the resistive term of the pseudocapacitance.
  • the presence of the current enhancements is thus a complex process involving a variety of factors and their interactions in the electrochemical cell and with the electrodes (see, for example, Instrumental methods in electrochemistry, Horwood publishing, 2001, section 2.4.4, page 67). Such factors involve not only the electrode surfaces, but also the impact of surface-active agents and processes such as freeze drying, laser drilling of the electrodes and reagent mixing.
  • the sample comes into contact an electrochemical cell comprising at least two electrodes.
  • a device according to one embodiment of the invention is depicted in Figure 1.
  • the device comprises a strip [S] comprising four electrochemical cells [C] and an electronics unit [E], e.g. a handheld portable electronics unit, capable of forming electronic contact with the strip [S].
  • the electronics unit [E] may, for example, house a power supply for providing a potential to the electrodes, as well as a measuring instrument for detecting an electrochemical response and any other measuring instruments required.
  • a computer program may be operated by a computer program.
  • the electrochemical cell [C] may be a two-electrode, a three-electrode, a four- electrode or a multiple-electrode system.
  • a two-electrode system comprises a working electrode and a pseudo reference electrode.
  • a three-electrode system comprises a working electrode, an ideal or pseudo reference electrode and a separate counter electrode.
  • a pseudo reference electrode is an electrode that is capable of providing a substantially stable reference potential. In a two-electrode system, the pseudo reference electrode also acts as the counter electrode; in this case a current passes through, but does not analytically significantly perturb the reference potential.
  • an ideal reference electrode is an ideal non-polarisable electrode through which no current passes.
  • the electrochemical cell is in the form of a receptacle.
  • the receptacle may be in any shape as long as it is capable of containing a liquid which is placed into it.
  • the receptacle may be cylindrical.
  • a receptacle will contain a base and a wall or walls that surround the base. Suitable embodiments of electrochemical cells in the form of receptacles are, for example, disclosed in WO03056319.
  • the electrochemical cell may have at least one microelectrode, for example a microband electrode. If so, typically the working electrode is a microelectrode.
  • a microelectrode is an electrode having at least one dimension that comes into contact with the sample that does not exceed 50 ⁇ m.
  • the r microelectrodes of the invention may have a dimension that contacts with the sample that is macro in size, i.e. which is greater than 50 ⁇ m.
  • a typical microelectrode of the invention has one dimension of 50 ⁇ m or less and one dimension of greater than 50 ⁇ m (where the dimensions referred to are those in contact with the sample).
  • a microband electrode is defined as having one dimension more than 50 ⁇ m and one dimension less than 50 ⁇ m (where the dimensions referred to are those in contact with the sample).
  • a microband electrode is present in the cell in the shape of a band.
  • At least one of the at least two electrodes is a microelectrode.
  • one of the electrodes is a microband working electrode.
  • the electronics unit [E] comprises a voltage source arranged to selectively apply a voltage across the cell and a measurement circuit arranged to obtain measurements of an electrochemical parameter on the cell.
  • the unit may also comprise other features, such as a display panel to read out the measured electrochemical parameter.
  • the devices of the present invention may comprise two or more (e.g. three or four) electrochemical cells.
  • a plurality of strips may be used or the strip [S] may itself comprise a plurality of electrochemical cells.
  • This embodiment allows a number of measurements to be taken either substantially simultaneously or in a step-wise fashion.
  • the same or different reagent mixtures can be associated with each of the cells, allowing several identical measurements to be made or, for example, the concentrations of several different analytes in a sample to be measured simultaneously in a single device.
  • a potential is applied across the electrodes to generate a current.
  • the current generated as a function of time comprises a period of enhanced current, i.e. an enhancement of current for at least a part of the time from zero to ten seconds after application of the potential.
  • the applied potential is a substantially constant potential.
  • the potential may be applied in such a way that the potential is raised from zero to a final potential substantially immediately.
  • a time-varying potential can be applied to step the potential applied across two electrodes in electrical contact with a target solution between an initial and a final potential. Once the final potential has been substantially attained, the current flowing between the electrodes can be sampled. Further details on suitable time- varying potentials that may be applied to step the potential across the electrodes in this way are disclosed in WO2006030170, the content of which is herein incorporated by reference in its entirety.
  • references herein to times "after application of the potential” refer to times after the final (constant) potential has been substantially attaine ⁇ .
  • a substantially constant potential can if desired be attained over a short period of time, the precise period being subject to the specific configuration of the cell.
  • the sample Prior to application of the potential, the sample may be contacted with one or more other reagents.
  • These one or more other reagents may comprise one or more of a redox mediator, a surfactant, at least one enzyme, a coenzyme, a reductase, a cholesterol ester hydrolysing agent and a triglyceride hydrolysing reagent.
  • the one or more other reagents may be provided separately or in the form of a single reagent mixture.
  • the sample may be contacted with the one or more reagents before being contacted with the electrochemical cell, after being contacted with the electrochemical cell, or at the same time as being contacted with the electrochemical cell.
  • the one or more reagents may be present as a single reagent mixture comprised in the electrochemical cell, so that the sample contacts them at the same time as being contacted with the cell.
  • the sample is contacted with at least a surfactant. More preferably, the sample is contacted with at least a surfactant and a redox mediator.
  • the one or more other reagents are typically selected in accordance with the analyte to be detected in a particular embodiment of the invention.
  • the analyte is cholesterol (HDL, LDL or total) or triglyceride and accordingly the one or more other reagents are reagents suitable for carrying out an electrochemical test to detect either cholesterol (HDL, LDL or total) or triglyceride.
  • reagent mixtures and methods suitable for carrying out cholesterol (HDL, LDL or total) tests are described in WO2007/072013, WO 2006/067424, WO 2007/132223 and WO 2007/132226, the contents of all of which are herein incorporated by reference in their entirety.
  • the redox mediator is an electroactive substance capable of being oxidised or reduced to form a product, which on contact with the sample interacts with the analyte such that it is present in a concentration that is related to the concentration of the analyte. It therefore acts as a mediator, first being oxidised or reduced by the analyte (either directly, or via one or more intermediate species such as an enzyme) to form a product and then, on application of the potential, being reduced or oxidised to give rise to the electrochemical response of the cell.
  • the redox mediator may be a molecule or an ionic complex. It may be a naturally occurring electron acceptor such as a protein or may be a synthetic molecule. The redox mediator will have at least two oxidation states.
  • the redox mediator is an inorganic complex.
  • the mediator may comprise a metallic ion and will preferably have at least two valencies.
  • the mediator may comprise a transition metal ion.
  • Preferred transition metal ions include those of cobalt, copper, iron, chromium, manganese, nickel, osmium and ruthenium.
  • the redox mediator may be charged; for example, it may be cationic or alternatively anionic.
  • An example of a suitable cationic mediator is a ruthenium complex such as Ru(NH 3 ) 6 3+ .
  • An example of a suitable anionic mediator is a ferricyanide complex such as Fe(CN) 6 3" .
  • complexes which may be used include Cu(EDTA) " , Fe(CN) 6 " , Fe(CN) 5 (O 2 CR) 3" , Fe(CN) 4 (oxalate) 3” , Ru(NH 3 ) 6 3+ and chelating amine ligand derivatives thereof (such as ethylenediamine), Ru(NH 3 ) 5 (py) 3+ , cis-[bis(2,4- dioxopentan-3-ido)bis(3-pyridine carboxylic acid)-Ruthenium (IH)], ferrocenium and derivatives thereof with one or more of groups such as -NH 2 , -NHR, -NHC(O)R, for example, ferrocenium monocarboxylic acid (FMCA), and -CO 2 H substituted into one or both of the two cyclopentadienyl rings.
  • M is ruthenium or osmium and has an oxidation state of 0, 1 , 2, 3 or 4; x and n are independently an integer selected from 1 to 6; y is an integer selected from 1 to 5; m is an integer from -5 to +4 and z is an integer from -2 to +1 ;
  • A is a mono- or bidentate aromatic ligand containing 1 or 2 nitrogen atoms
  • B is independently selected to be any suitable ligand other than a heterocyclic nitrogen-containing ligand
  • X is any suitable counter ion; wherein A is optionally substituted by 1 to 8 groups independently selected from substituted or unsubstituted alkyl, alkenyl, or aryl groups
  • Such complexes are those of formula [M(A) x (B) y ] m (X z ) n wherein M is ruthenium or osmium and has an oxidation state of 0, 1, 2, 3 or 4; x and n are independently an integer selected from 1-6; y is an integer selected from 0-5; m is an integer from -5 to +4 and z is an integer from -2 to +1 ; A is a bi-, tri-, tetra-, penta- or hexadentate ligand which can be either linear having the formula R I RN(C 2 H 4 NR)WR' or cyclic having the formulae (RNC 2 H 4 ) V , (RNC 2 H 4 ) p (RNC 3 H 6 ) q , or [(RNC 2 H 4 XRNC 3 H O )] S , wherein w is an integer from 1-5, v is an integer from 3-6, p and q are
  • Particularly preferred redox mediators are Ru(acac) 2 (Py-3-CO 2 H)(Py-3-CO 2 )].H 2 O and Ru(m)(Me 3 TACN)(acac)(l-MeIm)](NO 3 ) 2 .
  • acac is the bidentate ligand acetylacetonate anion
  • CsH 7 O 2 " and TACN is the tridentate ligand 1,4,7-triazacyclononane.
  • Py means pyridine and Im means imidazole.
  • a surfactant can be used in order to break down lipoproteins to which triglycerides, cholesterol or cholesterol esters are incorporated.
  • surfactants suitable for use in the present invention include polyoxyethylene derivatives such as polyoxyethylene alkylene tribenzyl phenyl ether and polyoxyethylene alkylene phenyl ether, sucrose esters, maltosides, hydroxyethylglucamide derivatives, N-methyl-N- acyl glucamine derivatives and bile acid derivatives (or salts thereof).
  • Preferred surfactants include sucrose nionocaprate (“SMC”), Anameg-7 (Anatrace A340; Methyl- ⁇ -O-CN-heptylcarbamoy ⁇ - ⁇ -D-glucopyranoside) and bile acid derivatives such as CHAPS.
  • SMC sucrose nionocaprate
  • Anameg-7 Adatrace A340; Methyl- ⁇ -O-CN-heptylcarbamoy ⁇ - ⁇ -D-glucopyranoside
  • CHAPS bile acid derivatives
  • Cymal-2, Cymal-3, Cymal-4, Cymal-5, Cymal-6, Cymal-7 (which are 3- Cyclohexyl-1-alkyl- ⁇ -D-maltoside, where the "alkyl” moiety is ethyl, propyl, butyl, pentyl, hexyl and heptyl, respectively), Cyglu-3 (3-Cyclohexyl-l-propyl- ⁇ -D- glucoside), C-HEGA-10 (Cyclohexylbutanoyl-N-hydroxyethylglucamide), HEGA-9 (Nonanoyl-N-hydroxyethylglucamide), MEGA-8 (Octanoyl-N-methylglucamide), n- decyl- ⁇ -D-maltoside, n-undecyl- ⁇ -D-maltoside, n-heptyl- ⁇ -D-glucoside, n-octyl- ⁇ -
  • Cymal-2, Cymal-3, Cymal-4, Cymal-5, Cymal-6, Anameg-7, HEGA-9, MEGA-8, n-decyl- ⁇ -D-maltoside and n-heptyl- ⁇ -D-glucoside are most preferred.
  • the surfactant is typically provided in such an amount that when mixed with the sample to be tested the concentration of surfactant in the mixture of sample with the surfactant and any other reagents used is at least 1OmM, preferably at least 2OmM, for example at least 25mM.
  • the sample before the step b) the sample is contacted with:
  • a redox mediator selected from Ru(acac) 2 (Py-3-CO 2 H)(Py-3-CO 2 )].H 2 O and Ru(m)(Me 3 TACN)(acac)(l-MeIm)](NO 3 ) 2 , most preferably Ru(acac) 2 (Py-3- CO 2 H)(Py-3-CO 2 )].H 2 O; and
  • a surfactant selected from Cymal-2, Cymal-3, Cymal-4, Cymal-5, Cymal-6, Anameg-7, Cyglu-3, C-HEGA-10, HEGA-9, MEGA-8, n-decyl- ⁇ -D-maltoside, n- undecyl- ⁇ -D-maltoside, n-heptyl- ⁇ -D-glucoside, n-octyl- ⁇ -D-glucoside, octanoyl sucrose, sucrose monocaprate and dodecanyol sucrose, most preferably selected from Cymal-2, Cymal-3, Cymal-4, Cymal-5, Cymal-6, Anameg-7, HEGA-9, MEGA-8, n- decyl- ⁇ -D-maltoside and n-heptyl- ⁇ -D-glucoside.
  • the at least one enzyme is a species that is capable of catalysing a reaction between the analyte and the redox mediator.
  • Enzymes suitable for use in detecting triglyceride in a sample include (i) glycerol dehydrogenase and (ii) glycerol phosphate oxidase in combination with glycerol kinase, which may be used in conjunction in with the redox mediators of the invention and optionally further reagents.
  • An enzyme such as (i) cholesterol oxidase or (ii) cholesterol dehydrogenase is suitable for use in a formulation detecting cholesterol.
  • glycerol dehydrogenase Any commercially available forms of glycerol dehydrogenase, glycerol phosphate oxidase, glycerol kinase, cholesterol oxidase and cholesterol dehydrogenase may be employed.
  • the cholesterol dehydrogenase is, for example, from the Nocardia species.
  • the oxidase or dehydrogenase may be used in an amount of from O.Olmg to lOOmg per ml of reagent mixture, hi one embodiment, the oxidase or dehydrogenase is used in an amount of from 0.1 to 50 mg per ml of reagent mixture, preferably from 0.5 to 25 mg per ml.
  • the glycerol kinase is present in an amount of from 450 U/ml reagent mixture to 45000U/ml reagent mixture.
  • the coenzyme is capable of being reversibly oxidised and reduced.
  • the coenzyme becomes oxidised or reduced by reducing or oxidising the test analyte in the sample via the cholesterol oxidase or cholesterol dehydrogenase.
  • the coenzyme then oxidises or reduces the redox mediator (either directly or via one or more intermediate species).
  • An example of such an assay is shown below: Reduced
  • Cholestenone where ChD is cholesterol dehydrogenase cholesterol dehydrogenase.
  • cholesterol is oxidised to cholestenone by cholesterol dehydrogenase, which is oxidised by the coenzyme, which is then oxidised by the redox mediator.
  • the amount of reduced redox mediator produced by the assay (the "product") can then be detected electrochemically, by applying a potential across the cell and measuring the electrochemical response. Cholesterol dehydrogenase could be replaced with cholesterol oxidase in this assay if desired.
  • Suitable coenzymes include NAD + or an analogue thereof such as APAD (Acetyl pyridine adenine dinucleotide), TNAD (Thio-NAD), AHD (acetyl pyridine hypoxanthine dinucleotide), NaAD (nicotinic acid adenine dinucleotide), NHD (nicotinamide hypoxanthine dinucleotide), or NGD (nicotinamide guanine dinucleotide).
  • the coenzyme is typically present in the reagent mixture in an amount of from 1 to 25 mM, for example from 3 to 15 mM, preferably from 5 to 1OmM.
  • reductase typically transfers two electrons from the reduced coenzyme and transfers two electrons to the redox mediator.
  • the use of a reductase therefore provides swift electron transfer.
  • reductases which can be used include diaphorase and cytochrome P450 reductases, in particular, the putidaredoxin reductase of the cytochrome P450 cam enzyme system from Pseudomonas putida, the flavin (FAD/FMN) domain of the P450 BM - 3 enzyme from Bacillus megaterium, spinach ferrodoxin reductase, rubredoxin reductase, adrenodoxin reductase, nitrate reductase, cytochrome bs reductase, corn nitrate reductase, terpredoxin reductase and yeast, rat, rabbit and human NADPH cytochrome P450 reductases.
  • nitrate reductase preferably com nitrate reductase is used.
  • Preferred reductases for use in the present invention include diaphorase and putidaredoxin reductases.
  • the reductase may be a recombinant protein or a naturally occurring protein which has been purified or isolated.
  • the reductase may have been mutated to improve its performance such as to optimise the speed at which it carries out the electron transfer or its substrate specificity.
  • the reductase is typically present in the reagent mixture in an amount of from 0.5 to 100mg/ml, for example from 1 to 50mg/ml, 1 to 30 mg/ml or from 5 to 20 mg/ml.
  • the cholesterol ester hydro lysing reagent may be any reagent capable of hydro lysing cholesterol esters to cholesterol.
  • the reagent should be one which does not interfere with the reaction of cholesterol with cholesterol dehydrogenase and any subsequent steps in the assay.
  • Preferred cholesterol ester hydrolysing reagents are enzymes, for example cholesterol esterase and lipases.
  • a suitable lipase is, for example, a lipase from a pseudomonas or Chromobacterium viscosum species.
  • the cholesterol ester hydrolysing reagent may be used in an amount of from 0.1 to 25 mg per ml of sample, for example from 0.1 to 20mg per ml of sample, and preferably from 0.5 to 25 mg per ml, such as 0.5 to 15 mg per ml.
  • a glycerol enzyme is typically used to determine the triglyceride content.
  • the triglycerides which are liberated from the lipoproteins must therefore first be broken down to glycerol before reaction with the glycerol dehydrogenase or glycerol phosphate oxidase in combination with glycerol kinase. This is typically achieved by including a triglyceride hydrolysing reagent. Any reagent which hydrolyses triglycerides to glycerol may be used as long as it does not interfere with the activity of the dehydrogenase enzyme.
  • Lipases and esterases are suitable examples of triglyceride hydrolysing reagents.
  • the lipases described above as the cholesterol ester hydrolysing reagent are also appropriate for use in hydrolysing triglycerides.
  • the triglyceride hydrolysing reagent may be used in an amount of from 0.1 to 100 mg per ml of sample, for example from 0.1 to 70 mg per ml of sample, and preferably from 0.5 to 50 mg per ml, such as 0.5 to 25 mg per ml.
  • one or more measurements of current are obtained under conditions such that at least one measurement occurs in a period of enhanced current.
  • the period of enhanced current is as defined above.
  • Each measurement corresponds to a value of the current generated at a particular time after application of the potential.
  • a series of measurements are obtained, thus generating a current transient.
  • at least two measurements are obtained and more preferably at least ten, for example at least twenty.
  • At least one measurement occurs in the period of enhanced current, i.e. it corresponds to a value of the current generated at a time after application of the potential when the shoulder, or current enhancement, is present.
  • at least half of the measurements occur in said period of enhanced current. More preferably at least three quarters of the measurements occur in said period of enhanced current. Most preferably, substantially all, for example all, of the measurements occur in said period of enhanced current.
  • the electrical charging peaks as hereinbefore described are often observed in current transients and these are not thought to be related to the chemistry of the system under study (although it should be noted that the present invention is not any way limited to this theory). It is therefore to be understood that the one or more measurements in the present invention are obtained in a period where the purely non-faradaic "charging peak" contribution to the observed current is negligible. Typically the one or more measurements of current are thus obtained in the period beginning at least 0.05 seconds after application of the potential. Preferably, the one or more measurements of current are obtained in the period beginning at least 0.1 seconds after application of the potential, most preferably at least 0.15 seconds after application of the potential, for example at least 0.2 seconds after application of the potential.
  • the period of enhanced current is typically finished by ten seconds after application of the potential. Therefore, the least one measurement occurring in the period of enhanced current is/are typically obtained in the period up to a maximum often seconds after application of the potential. In a preferred embodiment, said at least one measurement is/are obtained in the period up to a maximum of eight seconds after application of the potential, for example up to a maximum of five seconds.
  • the concentration of the analyte After the one or more measurements of current have been obtained, these are used to determine the concentration of the analyte.
  • the magnitude of the electrochemical response of the cell can be correlated with the concentration of the analyte. This correlation can, for example, be achieved with reference to calibration data obtained in advance using samples having known analyte concentrations.
  • the analyte concentration can be obtained, for example, by correlating a single measurement of current response in the period of enhanced current to calibration data. Alternatively, a simple average or appropriately weighted average of two or more current measurements can be used.
  • the concentration of the analyte is determined by: calculating from at least two measurements the total charge passed in the period over which the measurements have been obtained; and determining the concentration of the analyte from said total charge passed.
  • the total charge passed is the integral of the current over the period over which said measurements have been obtained. This method is particularly preferred when substantially all of the current measurements have been obtained in the period of enhanced current, because it allows all of the enhanced experimentally observed current to be used in determining the analyte concentration. It will be appreciated that a rigorous determination of the integral of current over time is not necessarily required. For example, a suitable estimate of the total charge passed could be obtained as an area under a graph of current as a function of time, or even as a simple summation of current measurements obtained at a series of time points.
  • the concentration of the analyte is determined by: calculating from at least two measurements the experimental total charge passed in the period over which the measurements have been obtained; determining a predicted current for the period of time from application of the potential to ten seconds after application of the potential; - using the predicted current to calculate the predicted total charge passed in the period over which the measurements have been obtained; and determining the concentration of the analyte from the difference between the experimental and predicted total charge passed.
  • the predicted current can be determined, for example, using a suitable well-known theoretical equation, such as those described above adapted appropriately for the specific system under study. Alternatively, it can be determined empirically, by determining the relationship between the current and time in a period of time beginning at least ten seconds after application of the potential and then using that relationship to extrapolate back to a predicted current in the period over which the measurements have been made.
  • the present invention provides a method for determining the concentration of an analyte in a sample, which method comprises: a) contacting said sample with an electrochemical cell comprising at least two electrodes, one of which is a microband electrode; b) applying a potential across the electrodes to generate a peak current, which subsequently decays; c) obtaining one or more measurements of said current under conditions such that at least one of said measurements occurs in a period during which the current is decaying; and d) determining the concentration of said analyte from said one or more measurements.
  • step b) comprises applying a potential across the electrodes to generate a peak current, which subsequently decays to a substantially steady state current and that in step c) at least one of said measurements occurs before the current is a substantially steady state current. More preferably, the substantially steady state current is a substantially constant current.
  • Handheld biosensor device A device of the type depicted in Figure 1 and described in detail in WO
  • 2007/072013 having four electrochemical cells comprised in the strip [S], was used.
  • Each electrochemical cell comprised a carbon working electrode and a Ag/ AgCl pseudo reference electrode.
  • the volume of each cell was approximately 0.6 ⁇ l.
  • the dispensed sensor sheets were then placed into a LS40 freeze drier (Severn Science) for freeze drying.
  • test samples were prepared in delipidated serum (Scipac): (i) 0 mM NADH (ii) 2.5 mM NADH (iii) 5.O mM NADH
  • / is the microband current
  • F is the Faraday constant (96485 C/mol)
  • A is the electrode area
  • n is the number of electrons involved in the electrochemical reaction
  • D 0x is the diffusion coefficient of the mediator
  • [Ox] is the concentration of reduced mediator
  • w is the width of the microband electrode
  • t is the time.
  • a grade scale for the magnitude of the shoulder was constructed based on the percentage difference between the observed current value and the theoretical current value at 0.5 second time intervals along the transient current response.
  • a shoulder was assigned a grade of 'N', where N is equal to twice the longest time point at which the average difference between the observed and theoretical currents was greater than 10%.
  • a grade of zero would have been assigned if the average percentage difference was less than 10% at the first time point (0.5 seconds).
  • Typical current transients for the HEGA 9 system are shown in Figure 3 for each of the three NADH analyte concentrations: Graph A is for 2.5 mM NADH, Graph B is for 5 mM NADH and graph C is for 7.5 mM NADH. Also shown on these graphs are the fitted theoretical responses obtained using the microband equation (as explained above).
  • Figure 5 shows the cumulative difference between the area under the curve of (i) actual current response and (ii) theoretical current response for the Cymal 3 system.
  • the Figure clearly shows that an enhanced charge is passed as a result of the period of current enhancement.
  • the gradient of the plot of cumulative difference then tends towards zero as the period of current enhancement comes to an end.
  • Figure 6 shows a plot of cumulative area (i.e., the total integral, starting from 0.15 seconds, of current response up to a particular time) versus NADH concentration where the final time up to which current was integrated was 1 second, 3 seconds or 8 seconds, for the Cymal 3 system. Again, this shows that measurement of current, in this case integrated to obtain charge, in the shoulder period is capable of providing an assay system for quantifying NADH concentration.
  • Figure 7 shows the same data, but for the HEGA 9 system.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Electrochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé électrochimique pour déterminer la concentration d'un analyte dans un échantillon. La concentration est déterminée à l'aide de mesures du courant généré dans une période caractéristique de courant accru apparaissant peu après qu'un potentiel a été appliqué aux bornes des électrodes.
PCT/GB2009/001911 2008-08-04 2009-08-04 Amélioration de réponse électrochimique Ceased WO2010015812A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0814238A GB0814238D0 (en) 2008-08-04 2008-08-04 Enhancement of electrochemical response
GB0814238.2 2008-08-04

Publications (1)

Publication Number Publication Date
WO2010015812A1 true WO2010015812A1 (fr) 2010-02-11

Family

ID=39767485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001911 Ceased WO2010015812A1 (fr) 2008-08-04 2009-08-04 Amélioration de réponse électrochimique

Country Status (2)

Country Link
GB (1) GB0814238D0 (fr)
WO (1) WO2010015812A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012052755A1 (fr) * 2010-10-19 2012-04-26 Isis Innovation Limited Procédé de détection électrochimique
GB2493718A (en) * 2011-08-15 2013-02-20 Schlumberger Holdings Electrochemical sensor with surfactants
WO2014072820A3 (fr) * 2012-11-08 2014-07-17 Thomas William Beck Dispositifs et procédés chrono-ampérométriques de quantification électrochimique de substances à analyser

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020053523A1 (en) * 1999-11-04 2002-05-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
WO2003040728A2 (fr) * 2001-11-07 2003-05-15 Roche Diagnostics Gmbh Instrument
WO2006030170A1 (fr) * 2004-08-17 2006-03-23 Oxford Biosensors Limited Detecteur electrochimique
US20080102441A1 (en) * 2006-10-31 2008-05-01 Ting Chen Analyte Sensors and Methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020053523A1 (en) * 1999-11-04 2002-05-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
WO2003040728A2 (fr) * 2001-11-07 2003-05-15 Roche Diagnostics Gmbh Instrument
WO2006030170A1 (fr) * 2004-08-17 2006-03-23 Oxford Biosensors Limited Detecteur electrochimique
US20080102441A1 (en) * 2006-10-31 2008-05-01 Ting Chen Analyte Sensors and Methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012052755A1 (fr) * 2010-10-19 2012-04-26 Isis Innovation Limited Procédé de détection électrochimique
GB2493718A (en) * 2011-08-15 2013-02-20 Schlumberger Holdings Electrochemical sensor with surfactants
US9523667B2 (en) 2011-08-15 2016-12-20 Schlumberger Technology Corporation Electrochemical sensor system
WO2014072820A3 (fr) * 2012-11-08 2014-07-17 Thomas William Beck Dispositifs et procédés chrono-ampérométriques de quantification électrochimique de substances à analyser

Also Published As

Publication number Publication date
GB0814238D0 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
US10908112B2 (en) Rapid-read gated amperometry devices
EP1398386B1 (fr) Compositions pour stabiliser un médiateur et utilisation de ces compositions dans des méthodes de détection électrochimiques
CN101849180B (zh) 多区域分析物测试传感器
Huang et al. Ultrasensitive cholesterol biosensor based on enzymatic silver deposition on gold nanoparticles modified screen-printed carbon electrode
AU705165B2 (en) Electrochemical method
US6214612B1 (en) Cholesterol sensor containing electrodes, cholesterol dehydrogenase, nicotinamide adenine dinucleotide and oxidized electron mediator
CN101522095A (zh) 瞬时衰变电流分析法
HK1049881A1 (en) Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
US20110297540A1 (en) Low Total Salt Reagent Compositions and Systems for Biosensors
WO2010015812A1 (fr) Amélioration de réponse électrochimique
Canbay et al. Development An Amperometric Microbial‐enzyme Hybrid Cholesterol Biosensor Based On Ionic Liquid MWCNT Carbon Paste Electrode
Hájková-Strejcová et al. New strategy in electrochemical investigation of DNA damage demonstrated on genotoxic derivatives of fluorene
EP2160596A1 (fr) Méthodologie de rejet de données électrochimiques
WO2019243314A1 (fr) Procédé électrochimique enzymatique pour la quantification d'analytes dans des échantillons de fluides biologiques
US20100330596A1 (en) Lipoprotein surfactant
US20110031988A1 (en) Reducing signal distortions
KR20110034730A (ko) 더블 펄스 방식을 이용한 바이오센서
HK1243163A1 (en) Measurement device, biosensor system and method for determining concentration of analyte
HK1146302A (en) Rapid-read gated amperometry
HK1062032B (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09784859

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09784859

Country of ref document: EP

Kind code of ref document: A1